DK704088D0 - Tricycliske forbindelser, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter - Google Patents

Tricycliske forbindelser, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter

Info

Publication number
DK704088D0
DK704088D0 DK704088A DK704088A DK704088D0 DK 704088 D0 DK704088 D0 DK 704088D0 DK 704088 A DK704088 A DK 704088A DK 704088 A DK704088 A DK 704088A DK 704088 D0 DK704088 D0 DK 704088D0
Authority
DK
Denmark
Prior art keywords
lower alkoxy
integer
carbon
lower alkyl
diseases
Prior art date
Application number
DK704088A
Other languages
English (en)
Other versions
DK704088A (da
Inventor
Armin Walser
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK704088D0 publication Critical patent/DK704088D0/da
Publication of DK704088A publication Critical patent/DK704088A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK704088A 1987-12-18 1988-12-16 Tricycliske forbindelser, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter DK704088A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13472687A 1987-12-18 1987-12-18
US22794888A 1988-08-03 1988-08-03

Publications (2)

Publication Number Publication Date
DK704088D0 true DK704088D0 (da) 1988-12-16
DK704088A DK704088A (da) 1989-06-19

Family

ID=26832617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK704088A DK704088A (da) 1987-12-18 1988-12-16 Tricycliske forbindelser, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter

Country Status (21)

Country Link
EP (1) EP0320992B1 (da)
JP (1) JPH0725762B2 (da)
KR (1) KR890009932A (da)
CN (1) CN1031057C (da)
AT (1) ATE109148T1 (da)
AU (1) AU612441B2 (da)
CA (1) CA1327570C (da)
CS (1) CS833288A2 (da)
DE (1) DE3850866T2 (da)
DK (1) DK704088A (da)
ES (1) ES2056889T3 (da)
FI (1) FI88799C (da)
HU (1) HU204273B (da)
IE (1) IE63762B1 (da)
IL (1) IL88688A0 (da)
MC (1) MC1999A1 (da)
NO (1) NO167920C (da)
NZ (1) NZ227341A (da)
PT (1) PT89250B (da)
RU (1) RU2094436C1 (da)
YU (1) YU46991B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
JP2959598B2 (ja) * 1990-10-12 1999-10-06 吉富製薬株式会社 光学活性なチエノトリアゾロジアゼピン化合物
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes
WO1994006802A1 (fr) * 1992-09-18 1994-03-31 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienodiazepine et son utilisation medicinale
US5302590A (en) * 1992-12-18 1994-04-12 Hoffmann-La Roche Inc. Compounds useful as dual antagonists of platelet activating factor and leukotriene D4
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
EP1925614A1 (en) * 2002-03-28 2008-05-28 Wisys Technology Foundation, Inc. Anxiolytic agents with reduced sedative and ataxic effects
BR0308918A (pt) 2002-03-28 2005-01-04 Wisys Technology Found Inc Agentes ansiolìticos com efeitos sedativos e atáxicos reduzidos
CA2570185A1 (en) 2004-06-30 2006-01-12 Wisys Technology Foundation Inc. Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
BRPI0513811A (pt) * 2004-07-27 2008-07-15 Gilead Sciences Inc imidazo [4,5-d] pirimidinas, seus usos e processos de preparação
JP2008512456A (ja) * 2004-09-09 2008-04-24 メルク エンド カムパニー インコーポレーテッド 三環式アニリドスピロラクタムcgrp受容体拮抗薬
ATE518852T1 (de) * 2004-09-13 2011-08-15 Merck Sharp & Dohme Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten
DK1802625T3 (da) * 2004-10-13 2008-09-01 Hoffmann La Roche Disubstituerede pyrazolobenzodiazepiner der er nyttige som inhibitorer af CDK2 og angiogenese og til behandling af bryst-, tyktarms-, lunge- og prostatacancer
ES2526671T3 (es) * 2010-06-22 2015-01-14 Glaxosmithkline Llc Compuestos de benzotriazoldiazepina inhibidores de bromodominios
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
UA110640C2 (uk) * 2011-05-05 2016-01-25 Янссен Фармацевтика Нв ПРОТИГРИБКОВІ 5,6-ДИГІДРО-4Н-ПІРОЛО[1,2-a][1,4]БЕНЗОДІАЗЕПІНИ ТА 6Н-ПІРОЛО[1,2-a][1,4]БЕНЗОДІАЗЕПІНИ, ЯКІ ЗАМІЩЕНІ ГЕТЕРОЦИКЛІЧНИМИ ПОХІДНИМИ
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
WO2014179567A2 (en) * 2013-05-01 2014-11-06 Academia Sinica Methods and compositions for treating beta-thalassemia and sickle cell disease
CN103694253A (zh) * 2013-11-04 2014-04-02 湖南华腾制药有限公司 一种噻吩并三唑并[4,3-a][1,4]二氮杂卓类化合物的制备方法
PL3157928T3 (pl) 2014-06-20 2019-07-31 Constellation Pharmaceuticals, Inc. Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu
JP7139323B2 (ja) * 2016-11-01 2022-09-20 エフ.ホフマン-ラ ロシュ アーゲー Cns関連疾患を処置するための1,3-ジヒドロ-1,4-ベンゾジアゼピン-2-チオン
CR20230211A (es) * 2020-11-16 2023-07-13 Boehringer Ingelheim Int Derivados de ciclopentatiofen carboxamida como antagonistas del receptor del factor de activación de plaquetas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
DE3778559D1 (de) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg Thieno-1,4-diazepine.
DE3610848A1 (de) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg Neue 1,4-diazepine
EP0315698B1 (en) * 1987-05-28 1993-03-03 Yoshitomi Pharmaceutical Industries, Ltd. Thieno(triazolo)diazepine compounds and medicinal application of the same

Also Published As

Publication number Publication date
AU612441B2 (en) 1991-07-11
HUT50823A (en) 1990-03-28
FI88799B (fi) 1993-03-31
FI885820A0 (fi) 1988-12-16
NO167920B (no) 1991-09-16
NO167920C (no) 1991-12-27
NO885597L (no) 1989-06-19
FI885820A7 (fi) 1989-06-19
NZ227341A (en) 1992-01-29
MC1999A1 (fr) 1990-01-26
KR890009932A (ko) 1989-08-05
ATE109148T1 (de) 1994-08-15
IE883758L (en) 1989-06-18
IL88688A0 (en) 1989-07-31
JPH01197484A (ja) 1989-08-09
YU46991B (sh) 1994-11-15
CN1031057C (zh) 1996-02-21
HU204273B (en) 1991-12-30
CN1034722A (zh) 1989-08-16
NO885597D0 (no) 1988-12-16
EP0320992A3 (en) 1991-01-09
DE3850866T2 (de) 1994-12-08
FI88799C (fi) 1993-07-12
JPH0725762B2 (ja) 1995-03-22
CA1327570C (en) 1994-03-08
PT89250B (pt) 1993-07-30
RU2094436C1 (ru) 1997-10-27
EP0320992B1 (en) 1994-07-27
AU2698988A (en) 1989-06-29
YU228088A (en) 1990-06-30
ES2056889T3 (es) 1994-10-16
PT89250A (pt) 1989-12-29
EP0320992A2 (en) 1989-06-21
IE63762B1 (en) 1995-06-14
CS833288A2 (en) 1990-10-12
DK704088A (da) 1989-06-19
DE3850866D1 (de) 1994-09-01

Similar Documents

Publication Publication Date Title
DK704088A (da) Tricycliske forbindelser, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter
FI820281L (fi) Foerfarande foer framstaellning av 2-penemkompositioner med forfarandet framstaellda nya 2-penemkompositioner och dessa inehaollande farmaceutiska blandningar
EE9400357A (et) Triasolopüridasiini ühendid, nende valmistamine ja kasutamine
ES8404349A1 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
IL70288A (en) 1-carbonyl-1-phenyl-2-azolyl-ethanol derivatives,their preparation and their use as microbicides and plant growth regulants
ES8507090A1 (es) Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas
ES8300762A1 (es) Un procedimiento para la preparacion de benzamidas.
ES8606337A1 (es) Un procedimiento para preparar nuevas benzamidas con actividada antagonista de 5-ht.
PT74199B (de) Neue trisubstituierte pyrimido<5,4-d>pyrimidine ihre herstel- lung und ihre verwendung als arzneimittel
ES8304579A1 (es) Un procedimiento para la preparacion de orto (sulfonil) oxibenceno-sulfonamidas.
DE69106902D1 (de) Imidazopyridazine, ihre Herstellung und Verwendung.
IE780182L (en) N-9,10-DIHYDROLYSERGYL-m-AMINOBENZOIC ACID AMIDES.
SE7704615L (sv) Sett att framstella nya 1,4-bensodioxanderivat
NO894384L (no) Forbindelser for behandling av urininkontinens.
JPS6429367A (en) 2-amino-5-hydroxy-4-pyrimidone
DE2961326D1 (en) New 1,2,4-triazole derivatives, a process for their manufacture and pharmaceutical compositions containing them
HUT53089A (en) Process for producing cyclic guanidine derivatives of calcium-antagonistic activity and pharmaceutical compositions containing them
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
FI874107A7 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara piperidinderivat.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment